The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study
Abstract
A higher risk of cardiovascular events has been reported in patients with primary aldosteronism (PA) than in otherwise similar patients with essential hypertension (EH). However, the evidence is limited by small sample size and potential confounding factors. We, therefore, compared the prevalence of cardiovascular events in 459 patients with PA diagnosed in our hypertension unit from 2001 to 2006 and 1290 controls with EH. PA cases and EH controls were individually matched for sex, age (±2 years), and office systolic blood pressure (±10 mm Hg). Patients with PA and EH differed significantly in duration of hypertension, serum potassium, plasma aldosterone and plasma renin concentrations, aldosterone-to-renin ratio, and urinary aldosterone concentration (P<0.001 for all comparisons). The prevalence of electrocardiographic and echocardiographic left ventricular hypertrophy was about twice higher in patients with PA even after adjustment for hypertension duration. PA patients also had a significantly higher prevalence of coronary artery disease (adjusted odds ratio, 1.9), nonfatal myocardial infarction (adjusted odds ratio, 2.6), heart failure (adjusted odds ratio, 2.9), and atrial fibrillation (adjusted odds ratio, 5.0). The risks associated with PA were similar across levels of serum potassium and plasma aldosterone. To conclude, patients with PA are more likely to have had a cardiovascular complication at diagnosis than otherwise similar patients with EH. Target organ damage and complications disproportionate to blood pressure should be considered as an additional argument for suspecting PA in a given individual and possibly for broadening the scope of screening at the population level.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary aldosteronism is also associated with left ventricular hypertrophy, diastolic dysfunction and heart failure, large artery stiffness, oxidative stress, widespread tissue inflammation and fibrosis, and increased resistance vessel remodeling compared with primary hypertension.291–293”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [291]
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Universal Definition of Myocardial Infarction
Thygesen, K. A., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Mendis, S., Implementation Group: Lars C. Wallentin Coordinator (Sweden), F. F.-A. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,422
Thygesen, K. A. (2007) · Circulation · Cited by 3,126
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Sokolow, M., & Lyon, T. P. (1949) · American Heart Journal · doi:10.1016/0002-8703(49)90562-1 · Cited by 1,990
(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
Self-citationSIMONE, G. D., Devereux, R. B., Daniels, S. R., Koren, M. J., Meyer, R. A., & Laragh, J. H. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00540-7 · Cited by 900
Oxford textbook of clinical nephrology
Cameron, S. M. (2013) · Oxford University Press eBooks · Cited by 717
Cited by
Sorted by citations
Items 401–500 of 503
Tumores de la glándula suprarrenal
Libé, R., & Bertherat, J. Y. (2016) · EMC - Urología · doi:10.1016/s1761-3310(16)77898-4 · Cited by 1
Srinivasa, R. N., Anderson, M., Dackiw, A. P. B., Pillai, A. K., Trimmer, C. K., Kalva, S. P., & Reis, S. P. (2017) · Journal of Clinical Interventional Radiology ISVIR · doi:10.1055/s-0037-1602769 · Cited by 1
Soh, L. M. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_27 · Cited by 1
Progrès récents dans la génétique de l’hyperaldostéronisme primaire
Zennaro, M., Fernandes-Rosa, F. L., & Boulkroun, S. (2015) · médecine/sciences · doi:10.1051/medsci/20153104013 · Cited by 1
Piazza, M., Hanssen, N. M. J., Scheijen, J. L. J. M., van de Waarenburg, M. P. H., Caroccia, B., Seccia, T. M., Stehouwer, C. D. A., Rossi, G. P., & Schalkwijk, C. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00773-y · Cited by 1
Ayala, A. R., & Jara, M. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-86099-7_21 · Cited by 1
Manolis, A. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734299250.793571584 · Cited by 1
Novel aspects of the Renin-Angiotensin-Aldosterone System
Piazza, M. (2021) · doi:10.26481/dis.20211004mp · Cited by 1
Aldosterone and Cardiovascular Diseases
Tomaschitz, A., & Pilz, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_12
Steichen, O. (2013) · HAL
Self-citationPRIMARY ALDOSTERONISM STUDIES ON SCREENING, OUTCOME OF ADRENALECTOMY AND FUNCTIONAL PATHOLOGY
Volpe, C. (2013) · Figshare
Prejbisz, A., Klisiewicz, A., Dobrowolski, P., Janaszek−Sitkowska, H., Warchoł-Celińska, E., Kołodziejczyk‐Kruk, S., Janas, J., Kabat, M., Imiela, J., & Januszewicz, A. (2013)
Génétique des hyperaldostéronismes
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2015) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2015.09.014
Genetic Alterations and Molecular Signatures in Aldosterone Producing Adenomas
Åkerström, T. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Bilan étiologique de l’HTA : dosages hormonaux toujours avant imagerie ?
Chamontin, B., Séguro, F., Touront, N., & Bouhanick, B. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.06.009 · Cited by 1
Boulestreau, R., Crémer, A., & Gose, P. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.07.140
Primary Aldosteronism in the Primary Care Clinic: Rife or Rare?
Byrd, J. B. (2016) · Endocrine Practice · doi:10.4158/ep161511.co
Tuka, V., Matoulek, M., Zelinka, T., Rosa, J., Petrák, O., Mikes, O., Krátká, Z., Štrauch, B., Holaj, R., & Widimsky, J., Jr. (2017) · Physiological Research · doi:10.33549/physiolres.933320
Prise en charge anesthésiologique lors de chirurgie surrénalienne
Schläpfer, P., Albrecht, E., Baumgartner, M., & Blanc, C. (2016) · Time to knit · doi:10.1016/s0246-0289(16)59011-2
Diagnóstico diferencial del hiperaldosteronismo primario
Rodríguez, M. D. M. R., Mendiguchía, L. J., Rosillo, M., & Cano, A. M. G. (2017) · Revista del Laboratorio Clínico · doi:10.1016/j.labcli.2017.02.002
Anestesia-rianimazione nella chirurgia surrenalica
Schläpfer, P., Albrecht, E., Baumgartner, M., & Blanc, C. (2017) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(17)84105-0
Monozygotic twins discordant for primary aldosteronism: a case report
Kobayashi, Y., Yatsu, K., Nakata-Shimokihara, K., Inoue, N., Fujikawa, T., Hirawa, N., Umemura, S., Satoh, F., Rossi, G. P., & Tamura, K. (2017) · Journal of Human Hypertension · doi:10.1038/jhh.2017.41
Clinical and Physiological Aspects of Salt Sensitive Hypertension
Wolley, M. J. (2017) · The University of Queensland · doi:10.14264/uql.2017.1041
Primary Aldosteronism and Its Various Scenarios
Martell‐Claros, N., Abad-Cardiel, M., Álvarez-Álvarez, B., & García‐Donaire, J. A. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_29
Primary Aldosteronism; Diagnosis and Treatment
Mantero, F., & Cicala, M. V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64327-1
Impact of Endocrine Disorders on Vasculature
Carbone, F., Bonaventura, A., Liberale, L., Vecchié, A., Casula, M., Dallegri, F., & Montecucco, F. (2019) · Ethical economy · doi:10.1007/978-3-319-66362-3_4-1
Germline and somatic genetic basis of primary aldosteronism
Fernandes-Rosa, F. L., Zennaro, M., & Boulkroun, S. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.08.015
Significance of General Laboratory Examination in the Diagnosis of Secondary Hypertension
Peng, Y., Cao, M., Zhao, X., Wang, L., & Aibaidula, Z. (2019) · Springer eBooks · doi:10.1007/978-981-15-0591-1_3
Kitahara, J., Ohkubo, Y., Kitajima, K., Nishio, S., Oiwa, A., Sato, A., Yamazaki, M., Sakuma, T., Sano, A., Nishii, Y., et al. (2020) · Institutional Repositories DataBase (IRDB) · doi:10.11441/shinshumedj.68.159
Hyperaldostéronisme primaire et syndrome métabolique
Cornu, E., Belmihoub, I., Baron, S., Azizi, M., & Amar, L. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.07.034
Self-citationAcar, N., Acar, T., Güngör, F., & Hacıyanlı, M. (2021) · doi:10.47829/vjs.2021.1101
The Management of Primary Hyperaldosteronism in a Poor Technology Environment
Jean, S., Georges, A. D. J., Inès, Y. D. M., Fanou, L., Natchagandé, G., Agounkpé, M. M., Hodonou, F. J.-M., Félicien, H. Y., & Atadokpèdé, F. (2021) · Case Reports in Urology · doi:10.1155/2021/6672052
Adrenal Gq Signaling: Implications for Maintenance of Zonation and Steroidogenesis
Taylor, M. J. (2019) · Deep Blue (University of Michigan)
Therapieresistente hypertensie
Deinum, J. (2013) · Bijblijven · doi:10.1007/s12414-013-0054-6
Ganta, N., Choe, S., Kanukuntla, A. K., Kata, P., & Cheriyath, P. (2021) · Cureus · doi:10.7759/cureus.17773
New clinical opportunities for mineralocorticoid receptor antagonists: focus on antifibrotic effects
Dragomiretskaya, N. A., Tarzimanova, A. I., Kucherova, Y. A., & Podzolkov, V. I. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.09.201016
Genetic Alterations in Aldosterone Producing Adenomas
Åkerström, T. (2014) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Ayala, A. R., & Jara, M. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-38976-5_21 · Cited by 1
Aldosterone and Its Cardiovascular Effects
Garg, R., & Adler, G. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803247-3.00026-x
Dorrance, A. M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736931179.793578066
Mineralocorticoids and Mineralocorticoid Excess Syndromes: Clinical Aspects
Freel, E. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65415-6
Beger, C., Haller, H. G., & Limbourg, F. P. (2022) · Die Nephrologie · doi:10.1007/s11560-022-00584-9
Effect of Hypokalemia on Screening for Primary AldosteronismPreprint
Rizer, N. W., Ding, X., Cohen, D. L., & Herman, D. S. (2022) · medRxiv · doi:10.1101/2022.06.16.22276370
Erector spinae plane blockade in the complex of anesthesia support of aldosteroma surgery
Neymark, M., Kiselev, R. V., & Goncharov, E. V. (2021) · Regional Anesthesia and Acute Pain Management · doi:10.17816/1993-6508-2021-15-3-215-222
Bases moléculaires du syndrome de Conn : rôle des canaux ioniques et formes anatomopathologiques
Zennaro, M., Fernandes-Rosa, F. L., & Boulkroun, S. (2022) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2022.03.011
Beger, C., Haller, H. G., & Limbourg, F. P. (2022) · Wiener klinisches Magazin · doi:10.1007/s00740-022-00457-w
Primary Aldosteronism Due to a Sub Centimeter Unilateral Adrenal Adenoma
Manov, A. (2020) · Open Access Journal of Endocrinology · doi:10.23880/oaje-16000154
Primary aldosteronism without hypertension: A case report and review of the literaturePreprint
Dimitrov, Y., Ott, J., Beguin, L., & Muller, B. (2022) · Research Square · doi:10.21203/rs.3.rs-2273269/v1
Adrenal cortical hormones and blood pressure regulation
Sanders, A., Fernandez, C. J., & Gama, R. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00019-4
Tumores de la glándula suprarrenal
Libé, R., & Bertherat, J. Y. (2023) · EMC - Urología · doi:10.1016/s1761-3310(22)47437-8
Impacto de una consulta de hipertensión endocrina en el diagnóstico del hiperaldosteronismo primario
Ruiz-Sánchez, J. G., & Meneses, D. (2023) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2023.02.004
Khalifa, A. A., & Hasan, M. M. (2023) · PERIÓDICO TCHÊ QUÍMICA · doi:10.52571/ptq.v20.n43.2023_02_hasan_12_25.pdf
Shi, Q., Zhang, M., Li, X., Chen, J., Du, Q., Chen, Y., Zhou, L., Zhao, H., Wang, L., Mao, M., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3114514/v1
Boulkroun, S., & Zennaro, M. (2023) · Endocrinology · doi:10.1007/978-3-031-27119-9_13
Preston, C., Yong, E. X. Z., Marginson, B., Farrell, S., Sawyer, M., Hahimura, H., Derbyshire, M. M., MacIsaac, R. J., & Sachithanandan, N. (2023) · Research Square · doi:10.21203/rs.3.rs-3608225/v1
Preoperative supine time for adrenal venous sampling: a prospective randomized controlled trial
He, M., Zhang, Y., Song, X., Zhang, T., Yu, H., Ji, Y., Gong, S., Chai, P., Chen, J., Wang, S., et al. (2024) · Trials · doi:10.1186/s13063-023-07872-2
Lin, B. S.-M., Robinson, L., Soliman, B., Gulizia, J., & Usala, S. J. (2024) · Medicina · doi:10.3390/medicina60010170
Yarita, M., Kidoguchi, S., Suehiro, Y., Sugano, N., & Yokoo, T. (2024) · Internal Medicine · doi:10.2169/internalmedicine.3116-23
Hiperaldosteronismo primario, una patología frecuente e infradiagnosticada: presentación de un caso
Clavijo, A. ́. G., Buitrago-Bermeo, A. F., & Cárdenas-Mesa, J. D. (2024) · Revista Médicas UIS · doi:10.18273/revmed.v37n1-2024002
MERCADO-ASIS, L. B., Gomez-Tuazon, F. C., Gan, F. R., & Malong, C. L. (2024) · Journal of Medicine University of Santo Tomas · doi:10.35460/2546-1621.2024-0044
Elevated renin activity and change in sleep apnea with primary aldosteronismPreprint
Kidawara, Y., Kadoya, M., Igeta, M., Kakutani‐Hatayama, M., Morimoto, A., Miyoshi, A., Kanzaki, A., Konishi, K., Daimon, T., & Koyama, H. (2024) · medRxiv · doi:10.1101/2024.08.01.24311390
Mineralocorticoids and mineralocorticoid excess syndromes: Clinical aspects
Freel, E. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00138-2
Primary aldosteronism: Diagnosis and treatment
Parksook, W. W., & Vaidya, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00135-7
Widjaja, J., Yang, J., & Harrison, J. (2024) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223241306952
Predicting Unilateral Aldosterone Secretion in Primary Aldosteronism
Mimouni, E., Amjad, W., Passman, J. E., Ginzberg, S. P., Trerotola, S. O., DePietro, D. M., Cohen, D. L., Roses, R. E., Fraker, D. L., & Wachtel, H. (2024) · Journal of Surgical Research · doi:10.1016/j.jss.2024.11.022
McEvoy, J. W., McCarthy, C. P., Brouwers, S., & Others, A. (2025) · HYPERTENSION · doi:10.22141/2224-1485.17.4.2024.372 · Cited by 1
Endocrine hypertension: From genes to biomarkers
Boulkroun, S., Zennaro, M., & Fernandes-Rosa, F. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00217-x
Cardiac function in children with congenital adrenal hyperplasia
Çetin, T., Akkuş, A., & Atar, M. (2025) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2025-0037
A Rare Case of Primary Hyperaldosteronism Resulting in Severe Hypokalemia
Sameer, S., Qassim, A. J., Aqel, A., Al-Asa’d, Y., & Thappy, S. (2025) · Cureus · doi:10.7759/cureus.82069
Prise en charge anesthésiologique lors de chirurgie surrénalienne
Rey, A., Cruchon, K., Kopp, P. A., Luzuy‐Guarnero, V., Zingg, T., Blanc, C., & Albrecht, E. (2025) · EMC-Anesthésie réanimation/Encyclopédie médico-chirurgicale. Anesthésie, réanimation · doi:10.1016/s0246-0289(24)48414-4
Primary Hyperaldosteronism Presenting as Cardiac Arrest: A Case Report
Saleem, M., Khan, M. M., Iftikhar, H., & Arif, H. (2025) · Cureus · doi:10.7759/cureus.86558
Fu, Q., Peng, S., Zhang, Y., Song, Y., Hu, J., Li, Q., He, Y., Yang, S., Wang, Y., on behalf of the Chongqing Primary Aldosteronism Study (CONPASS) Group, et al. (2025) · Endocrine · doi:10.1007/s12020-025-04326-4
Gestione anestesiologica durante la chirurgia surrenalica
Rey, A., Cruchon, K., Kopp, P. A., Luzuy‐Guarnero, V., Zingg, T., Blanc, C., & Albrecht, E. (2025) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(25)50688-6
Manejo anestésico en la cirugía de las glándulas suprarrenales
Rey, A., Cruchon, K., Kopp, P. A., Luzuy‐Guarnero, V., Zingg, T., Blanc, C., & Albrecht, E. (2025) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(25)50631-x
Hong, N., Kim, K. J., Yu, M. H., Jeong, S. H., Lee, S., Lim, J. S., & Rhee, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23935790
Jing, Y., Zhang, Y., Guo, H., Hou, R., Xu, J., Wang, J., Pan, X., Niu, X., Song, L., Huang, L., et al. (2026) · Journal of Clinical Hypertension · doi:10.1111/jch.70340
Yang, S., Wang, G., Li, N., & Zhu, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26587689
Yang, S., Wang, G., Li, N., & Zhu, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26587686
Hong, N., Kim, K. J., Yu, M. H., Jeong, S. H., Lee, S., Lim, J. S., & Rhee, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23935793
He, M., Zhang, Y., Song, X., Zhang, T., Yu, H., Ji, Y., Gong, S., Chai, P., Chen, J., Wang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24934061
Manosroi, W., Phudphong, P., Atthakomol, P., & Phimphilai, M. (2022) · Figshare · doi:10.6084/m9.figshare.20762958
Yang, S., Wang, G., Li, N., & Zhu, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26587683
Pathogenesis of primary aldosteronism
Ramírez, P. A. P., & Rojas‐Marcos, P. M. (2025) · Vitamins and hormones · doi:10.1016/bs.vh.2025.08.004
Thakur, M. K., Bhatt, M., Goyal, A., Singh, S., Roy, A., Alam, S., & Khadgawat, R. (2026) · Indian Heart Journal · doi:10.1016/j.ihj.2026.03.002
Genetic mechanisms of primary aldosteronism
Fayad, M., Cosentino, T., Faedda, N., Boulkroun, S., Zennaro, M., & Fernandes-Rosa, F. L. (2026) · Annales d Endocrinologie · doi:10.1016/j.ando.2026.102520
Effet de la modulation de l'équilibre calcique dans le cortex surrénalien
Fedlaoui, B. (2023) · theses.fr (ABES) · doi:10.70675/45da36b4z01fdz47d6za4b6z8663da88f35d
Interactions vasculaires et hormonales dans l'hyperaldostéronisme primaire
Abdellatif, A. B. (2022) · theses.fr (ABES) · doi:10.70675/5f0b4f73zaca0z4bc4z99d5z8ca373f11d25
Élaboration d'un modèle prédictif d'hypertension artérielle secondaire
de Fréminville, J.-B. (2025) · theses.fr (ABES) · doi:10.70675/7c5cc9e2z07ffz4f26zb8aez221757291584
Liu, H., Wu, Z., Liu, X., Hu, Y., Zhang, K., & Shang, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1802307
Dejprapasorn, S., Limumpornpetch, S., Lohawijarn, W., Choochuen, P., Chaochankit, W., & Limumpornpetch, P. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag123
Yazidi, M., Chihaoui, M., Kamoun, E., Sliman, C. B. H., Oueslati, I., Chaker, F., & Khessairi, N. (2026) · Journal of Human Hypertension · doi:10.1038/s41371-026-01159-0
Beyond aldosterone and renin: emerging biomarkers for diagnosing and subtyping primary aldosteronism
Libianto, R., Uniacke, C. L., Fuller, P. J., Young, M. J., & Yang, J. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag016
Barriers for Secondary Hypertension Screening in the United States: A National Physician Survey
Turcu, A. F., Salman, Z., Kromm, S. M., Zhang, L., Zhao, L., Suzer‐Gurtekin, Z. T., Vincent, G., & Papaleontiou, M. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.049858
Reprogramming of Iron and Oxygen Metabolism Across the Spectrum of Primary AldosteronismPreprint
Salle, S. P., Tsai, C., Newman, A. J., Heydarpour, M., Mahrokhian, S., Hanna, I., Brown, J. M., Waikar, S. S., Moussa, M., & Vaidya, A. (2026) · medRxiv · doi:10.64898/2026.06.09.26355256
Chow, M. W., Ng, C., Shen, J., Fuller, P. J., Yang, J., & Libianto, R. (2026) · Internal Medicine Journal · doi:10.1111/imj.70526
Eisa, N., & Khoury, M. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004367
Selective Cell Death of Adrenocortical Cells by Pharmacological Activation of Mutant KCNJ5
Mir-Bashiri, S., Rakete, S., Wei, J., Peitzsch, M., Hahner, S., Reincke, M., & Williams, T. A. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.27181
Metadata
- Authors
- Savard, S., Amar, L., Plouin, P.-F., & Steichen, O.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Venue
- Hypertension
- Published
- 2013-08
- Volume
- 62
- Issue
- 2
- Pages
- 331-336
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2168924012
- Cited by
- 505
- References
- 50
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 37 · 2023: 39 · 2022: 48 · 2021: 46 · 2020: 41 · 2019: 43 · 2018: 38 · 2017: 47 · 2016: 32 · 2015: 37 · 2014: 29 · 2013: 10
- FWCI
- 28.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Keywords
- primary aldosteronism, cardiovascular complications, essential hypertension, left ventricular hypertrophy, coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, aldosterone-renin ratio, serum potassium, plasma aldosterone, target organ damage
- MeSH terms
- Adult, Cardiovascular Diseases, Cross-Sectional Studies, Female, Humans, Hyperaldosteronism, Hypertension, Male, Middle Aged, Hypertrophy, Left Ventricular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review